在癌细胞中,MEMO1结合铁并调节铁的平衡
Natalia Dolgova1, Eva-Maria E Uhlemann1, Michal T Boniecki2
1Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Canada.
eLife
|April 19, 2024
概括
ERBB2驱动细胞运动1的媒介1 (MEMO1) 是一种结合铁的蛋白质. MEMO1调节癌细胞中的铁稳态,影响铁的分布和铁亡.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 生物化学 生物化学
背景情况:
- ERBB2驱动细胞机动性的媒介1 (MEMO1) 是一种参与各种生物过程的保存蛋白.
- 过度表达MEMO1与癌症有关,并通过改变细胞运动性来调节乳腺癌转移.
- MEMO1的精确分子功能在很大程度上是未知的.
研究的目的:
- 阐明MEMO1在癌细胞中的分子功能.
- 研究MEMO1与其他基因的遗传相互作用.
- 了解MEMO1在铁代谢和细胞过程中的作用.
主要方法:
- 使用来自1028个癌症细胞系的基因基本性数据对遗传相互作用的分析.
- 实验验证MEMO1与活细胞中与铁相关蛋白的相互作用.
- 生物化学测试以确定MEMO1的铁结合特性和MEMO1-铁/铜复合物的结构分析.
主要成果:
- 多个与铁相关的基因显示与MEMO1.1的遗传关系.
- 证实了MEMO1和关键铁蛋白之间的相互作用:转移素受体2 (TFR2),线粒激素-2 (SLC25A28) 和IRP1 (ACO1).
- MEMO1以高亲和力结合铁,其结构类似于含铁的二氧化酶,表明它在铁平衡和线粒体铁供应中发挥作用.
- MEMO1涉及到铁亡的过程.
结论:
- MEMO1是一种结合铁的蛋白质,在调节癌细胞内的铁平衡中起着至关重要的作用.
- MEMO1的功能与铁的分配,线粒体的铁供应和铁结有关.
- 了解MEMO1的铁结合能力,可以了解其在癌症进展和转移中的作用.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


